Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

308.17
Delayed Data
As of Aug 26
 +1.32 / +0.43%
Today’s Change
223.02
Today|||52-Week Range
333.65
+0.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line1.4B1.9B2.9B3.6B
 
 
 
 
 
Depreciation365.6M531.7M637.3M600.4M
 
 
 
 
 
Total Other Cash Flow147.4M108.7M155.9M243.6M
 
 
 
 
 
Funds From Operations1.8B2.3B3.4B4.3B
 
 
 
 
 
Funds From/For Other Operating Expenses-103.7M-87.4M484.4M575.5M
 
 
 
 
 
Net Cash Flow - Operating Activities1.9B2.3B2.9B3.7B
 
 
 
 
 
 
InvestingIncrease In Investments-3.4B-3.3B-3.6B-6.9B
 
 
 
 
 
Decrease In Investments2.8B5.2B2.7B4.1B
 
 
 
 
 
Capital Expenditures-254.5M-246.3M-287.8M-643.0M
 
 
 
 
 
Net Assets From Acquisitions -72.4M-15.0M0.00-198.8M
 
 
 
 
Other Investing - Uses0.000.00-391.0M-909.9M
 
 
 
Other Investing - Sources--7.4M0.000.00
 
 
Net Cash Flow Investing-950.3M-1.6B-1.5B-4.6B
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings0.00----5.9B
 
 
Long Term Debt Reduction-2.4M-452.3M-2.7M-2.1M
 
 
 
 
 
Net Proceeds Stock Sale67.5M66.8M54.9M54.2M
 
 
 
 
 
Common Preferred Redeemed-984.7M-400.3M-886.8M-5.0B
 
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing54.7M73.5M96.4M78.2M
 
 
 
 
 
Other Uses - Financing12.6M4.1M17.7M74.4M
 
 
 
 
 
Net Cash Flow - Financing-877.5M-716.5M-755.9M986.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash4.1M8.0M-40.9M-45.8M
 
 
 
 
 
 
Net Change In Cash52.1M23.9M643.3M148.9M